HomeNewsNeuroscience

  • NDA submitted for Brexanolone in Postpartum Depression by Sage Therapeutics

    • April 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Promius to present data from Migraine MAST study at AAN 2018

    • April 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments

    MAST seeks to shed light on the current state of migraine symptom characteristics and illustrate the state of migraine treatment.

    read more

  • Japan’s Takeda sweetens $62 billion Shire offer

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Brain Injury increases Parkinson’s risk, claims a latest study

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Amyloid blood biomarker detects Alzheimer’s disease

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Anavex to initiate Ph 2 study in Parkinson’s Disease for its drug ANAVEX®2-73

    • April 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Intranasal Esketamine improves Depression symptoms as per latest clinical trial results

    • April 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Results for Ibudilast Phase II trial in progressive MS to be presented at AAN

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Increasing Prevalence & Incidence rates for Alzheimer’s in Americans, report states

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more